As encouraging evidence for a beneficial effect of α2-AR antagonists have been reported for neurodegenerative disorders of diverging origins, namely AD, PD, and now HD, a globally acting mechanism, such as autophagy, could be contributing to the positive effects observed. The gene discussed is ADORA2A; the disease is Huntington disease.